Neutrophils in COVID-19
- PMID: 33841435
- PMCID: PMC8027077
- DOI: 10.3389/fimmu.2021.652470
Neutrophils in COVID-19
Abstract
Strong evidence has been accumulated since the beginning of the COVID-19 pandemic that neutrophils play an important role in the pathophysiology, particularly in those with severe disease courses. While originally considered to be a rather homogeneous cell type, recent attention to neutrophils has uncovered their fascinating transcriptional and functional diversity as well as their developmental trajectories. These new findings are important to better understand the many facets of neutrophil involvement not only in COVID-19 but also many other acute or chronic inflammatory diseases, both communicable and non-communicable. Here, we highlight the observed immune deviation of neutrophils in COVID-19 and summarize several promising therapeutic attempts to precisely target neutrophils and their reactivity in patients with COVID-19.
Keywords: COVID-19; SARS-CoV-2; clinical trials; granulocytes; neutrophils; scRNA-seq; viral infection.
Copyright © 2021 Reusch, De Domenico, Bonaguro, Schulte-Schrepping, Baßler, Schultze and Aschenbrenner.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
